-
1
-
-
0035499267
-
Stem cells, cancer, and cancer stem cells
-
Reya T, Morrison SJ, Clarke MF et al. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-111.
-
(2001)
Nature
, vol.414
, pp. 105-111
-
-
Reya, T.1
Morrison, S.J.2
Clarke, M.F.3
-
3
-
-
0344735881
-
Cancerous stem cells can arise from pediatric brain tumors
-
Hemmati HD, Nakano I, Lazareff JA et al. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 2003; 100:15178-15183.
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 15178-15183
-
-
Hemmati, H.D.1
Nakano, I.2
Lazareff, J.A.3
-
4
-
-
35848955428
-
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
-
Ginestier C, Hur MH, Charafe-Jauffret E et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007;1:555-567.
-
(2007)
Cell Stem Cell
, vol.1
, pp. 555-567
-
-
Ginestier, C.1
Hur, M.H.2
Charafe-Jauffret, E.3
-
5
-
-
62349116134
-
In vivo imaging, tracking, and targeting of cancer stem cells
-
Vlashi E, Kim K, Lagadec C et al. In vivo imaging, tracking, and targeting of cancer stem cells. J Natl Cancer Inst 2009;101: 350-359.
-
(2009)
J Natl Cancer Inst
, vol.101
, pp. 350-359
-
-
Vlashi, E.1
Kim, K.2
Lagadec, C.3
-
6
-
-
77956034139
-
Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment
-
Lagadec C, Vlashi E, Della Donna L et al. Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment. Breast Cancer Res 2010; 12:R13.
-
(2010)
Breast Cancer Res
, vol.12
-
-
Lagadec, C.1
Vlashi, E.2
Della Donna, L.3
-
7
-
-
80053166769
-
Metabolic state of glioma stem cells and nontumorigenic cells
-
Vlashi E, Lagadec C, Vergnes L et al. Metabolic state of glioma stem cells and nontumorigenic cells. Proc Natl Acad Sci USA 2011;108:16062-16067.
-
(2011)
Proc Natl Acad Sci USA
, vol.108
, pp. 16062-16067
-
-
Vlashi, E.1
Lagadec, C.2
Vergnes, L.3
-
8
-
-
0020354209
-
Protein turnover and proliferation. Failure of SV-3T3 cells to increase lysosomal proteinases, increase protein degradation and cease net protein accumulation
-
Lockwood TD, Minassian IA. Protein turnover and proliferation. Failure of SV-3T3 cells to increase lysosomal proteinases, increase protein degradation and cease net protein accumulation. Biochem J 1982;206: 251-258.
-
(1982)
Biochem J
, vol.206
, pp. 251-258
-
-
Lockwood, T.D.1
Minassian, I.A.2
-
9
-
-
0020420797
-
Protein turnover and proliferation. Turnover kinetics associated with the elevation of 3T3-cell acid-proteinase activity and cessation of net protein gain
-
Lockwood TD, Minassian IA, Roux L. Protein turnover and proliferation. Turnover kinetics associated with the elevation of 3T3-cell acid-proteinase activity and cessation of net protein gain. Biochem J 1982;206:239-249.
-
(1982)
Biochem J
, vol.206
, pp. 239-249
-
-
Lockwood, T.D.1
Minassian, I.A.2
Roux, L.3
-
10
-
-
21144450049
-
ATP hydrolysis-dependent disassembly of the 26S proteasome is part of the catalytic cycle
-
Babbitt SE, Kiss A, Deffenbaugh AE et al. ATP hydrolysis-dependent disassembly of the 26S proteasome is part of the catalytic cycle. Cell 2005;121:553-565.
-
(2005)
Cell
, vol.121
, pp. 553-565
-
-
Babbitt, S.E.1
Kiss, A.2
Deffenbaugh, A.E.3
-
11
-
-
0034759491
-
The proteasome in cancer biology and treatment
-
Pajonk F, McBride WH. The proteasome in cancer biology and treatment. Radiat Res 2001;156:447-459.
-
(2001)
Radiat Res
, vol.156
, pp. 447-459
-
-
Pajonk, F.1
McBride, W.H.2
-
12
-
-
29144487990
-
Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing
-
Cao R, Tsukada Y, Zhang Y. Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. Mol Cell 2005;20: 845-854.
-
(2005)
Mol Cell
, vol.20
, pp. 845-854
-
-
Cao, R.1
Tsukada, Y.2
Zhang, Y.3
-
13
-
-
28544438941
-
Destabilization of Kruppel-like factor 4 protein in response to serum stimulation involves the ubiquitin-proteasome pathway
-
Chen ZY, Wang X, Zhou Y et al. Destabilization of Kruppel-like factor 4 protein in response to serum stimulation involves the ubiquitin-proteasome pathway. Cancer Res 2005;65:10394-10400.
-
(2005)
Cancer Res
, vol.65
, pp. 10394-10400
-
-
Chen, Z.Y.1
Wang, X.2
Zhou, Y.3
-
14
-
-
70349871255
-
Acetylation of sox2 induces its nuclear export in embryonic stem cells
-
Baltus GA, Kowalski MP, Zhai H et al. Acetylation of sox2 induces its nuclear export in embryonic stem cells. Stem Cells 2009;27: 2175-2184.
-
(2009)
Stem Cells
, vol.27
, pp. 2175-2184
-
-
Baltus, G.A.1
Kowalski, M.P.2
Zhai, H.3
-
15
-
-
77955834772
-
Phosphorylation stabilizes Nanog by promoting its interaction with Pin1
-
Moretto-Zita M, Jin H, Shen Z et al. Phosphorylation stabilizes Nanog by promoting its interaction with Pin1. Proc Natl Acad Sci USA 2010;107:13312- 13317.
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, pp. 13312-13317
-
-
Moretto-Zita, M.1
Jin, H.2
Shen, Z.3
-
16
-
-
0030978351
-
Beta-catenin is a target for the ubiquitinproteasome pathway
-
Aberle H, Bauer A, Stappert J et al. Beta-catenin is a target for the ubiquitinproteasome pathway. EMBO J 1997;16:3797-3804.
-
(1997)
EMBO J
, vol.16
, pp. 3797-3804
-
-
Aberle, H.1
Bauer, A.2
Stappert, J.3
-
17
-
-
0035929669
-
The Notch intracellular domain is ubiquitinated and negatively regulated by the mammalian Sel-10 homolog
-
Oberg C, Li J, Pauley A et al. The Notch intracellular domain is ubiquitinated and negatively regulated by the mammalian Sel-10 homolog. J Biol Chem 2001;276:35847-35853.
-
(2001)
J Biol Chem
, vol.276
, pp. 35847-35853
-
-
Oberg, C.1
Li, J.2
Pauley, A.3
-
18
-
-
32044436273
-
Dual degradation signals control Gli protein stability and tumor formation
-
Huntzicker EG, Estay IS, Zhen H et al. Dual degradation signals control Gli protein stability and tumor formation. Genes Dev 2006;20:276-281.
-
(2006)
Genes Dev
, vol.20
, pp. 276-281
-
-
Huntzicker, E.G.1
Estay, I.S.2
Zhen, H.3
-
19
-
-
0347413734
-
Stem cells in normal breast development and breast cancer
-
Dontu G, Al-Hajj M, Abdallah WM et al. Stem cells in normal breast development and breast cancer. Cell Prolif 2003;36(suppl 1): 59-72.
-
(2003)
Cell Prolif
, vol.36
, Issue.SUPPL. 1
, pp. 59-72
-
-
Dontu, G.1
Al-Hajj, M.2
Abdallah, W.M.3
-
20
-
-
79951780026
-
Notch signaling contributes to the maintenance of both normal neural stem cells and patientderived glioma stem cells
-
Hu YY, Zheng MH, Cheng G et al. Notch signaling contributes to the maintenance of both normal neural stem cells and patientderived glioma stem cells. BMC Cancer 2011; 11:82.
-
(2011)
BMC Cancer
, vol.11
, pp. 82
-
-
Hu, Y.Y.1
Zheng, M.H.2
Cheng, G.3
-
21
-
-
18944375734
-
Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells
-
Dontu G, Jackson KW, McNicholas E et al. Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res 2004;6:R605-615.
-
(2004)
Breast Cancer Res
, vol.6
-
-
Dontu, G.1
Jackson, K.W.2
McNicholas, E.3
-
22
-
-
0033920919
-
Notch signal transduction: A real rip and more
-
Weinmaster G. Notch signal transduction: A real rip and more. Curr Opin Genet Dev 2000;10:363-369.
-
(2000)
Curr Opin Genet Dev
, vol.10
, pp. 363-369
-
-
Weinmaster, G.1
-
23
-
-
84862813490
-
The CCAAT boxbinding transcription factor NF-Y regulates basal expression of human proteasome genes
-
Xu H, Fu J, Ha SW et al. The CCAAT boxbinding transcription factor NF-Y regulates basal expression of human proteasome genes. Biochim Biophys Acta 2012;1823:818-825.
-
(2012)
Biochim Biophys Acta
, vol.1823
, pp. 818-825
-
-
Xu, H.1
Fu, J.2
Ha, S.W.3
-
24
-
-
84859036222
-
Radiation-induced reprograming of breast cancer cells
-
Lagadec C, Vlashi E, Della Donna L et al. Radiation-induced reprograming of breast cancer cells. Stem Cells 2012;30:833-844.
-
(2012)
Stem Cells
, vol.30
, pp. 833-844
-
-
Lagadec, C.1
Vlashi, E.2
Della Donna, L.3
-
25
-
-
78650827627
-
Context-dependent regulation of Musashimediated mRNA translation and cell cycle regulation
-
MacNicol MC, Cragle CE, MacNicol AM. Context-dependent regulation of Musashimediated mRNA translation and cell cycle regulation. Cell Cycle 2011;10:39-44.
-
(2011)
Cell Cycle
, vol.10
, pp. 39-44
-
-
Macnicol, M.C.1
Cragle, C.E.2
Macnicol, A.M.3
-
26
-
-
50849118492
-
Musashi1: A stem cell marker no longer in search of a function
-
Glazer RI, Wang XY, Yuan H et al. Musashi1: A stem cell marker no longer in search of a function. Cell Cycle 2008;7:2635-2639.
-
(2008)
Cell Cycle
, vol.7
, pp. 2635-2639
-
-
Glazer, R.I.1
Wang, X.Y.2
Yuan, H.3
-
27
-
-
84860167953
-
Structure of Musashi1 in a complex with target RNA: The role of aromatic stacking interactions
-
Ohyama T, Nagata T, Tsuda K et al. Structure of Musashi1 in a complex with target RNA: The role of aromatic stacking interactions. Nucleic Acids Res 2012;40:3218-3231.
-
(2012)
Nucleic Acids Res
, vol.40
, pp. 3218-3231
-
-
Ohyama, T.1
Nagata, T.2
Tsuda, K.3
-
28
-
-
0034237661
-
Apoptosis and radiosensitization of hodgkin cells by proteasome inhibition
-
Pajonk F, Pajonk K, McBride WH. Apoptosis and radiosensitization of hodgkin cells by proteasome inhibition. Int J Radiat Oncol Biol Phys 2000;47:1025-1032.
-
(2000)
Int J Radiat Oncol Biol Phys
, vol.47
, pp. 1025-1032
-
-
Pajonk, F.1
Pajonk, K.2
McBride, W.H.3
-
29
-
-
33749069075
-
ATP binding and ATP hydrolysis play distinct roles in the function of 26S proteasome
-
Liu CW, Li X, Thompson D et al. ATP binding and ATP hydrolysis play distinct roles in the function of 26S proteasome. Mol Cell 2006;24:39-50.
-
(2006)
Mol Cell
, vol.24
, pp. 39-50
-
-
Liu, C.W.1
Li, X.2
Thompson, D.3
-
30
-
-
34548180483
-
Immunoprecipitation of mRNA-protein complexes
-
Peritz T, Zeng F, Kannanayakal TJ, et al. Immunoprecipitation of mRNA-protein complexes. Nat Protoc 2006;1:577-580.
-
(2006)
Nat Protoc
, vol.1
, pp. 577-580
-
-
Peritz, T.1
Zeng, F.2
Kannanayakal, T.J.3
-
31
-
-
78149423083
-
26S proteasome activity is down-regulated in lung cancer stem-like cells propagated in vitro
-
Pan J, Zhang Q, Wang Y et al. 26S proteasome activity is down-regulated in lung cancer stem-like cells propagated in vitro. PLoS One 2010;5:e13298.
-
(2010)
PLoS One
, vol.5
-
-
Pan, J.1
Zhang, Q.2
Wang, Y.3
-
32
-
-
84862737662
-
Identification of pancreatic cancer stem cells and selective toxicity of chemotherapeutic agents
-
e237
-
Adikrisna R, Tanaka S, Muramatsu S et al. Identification of pancreatic cancer stem cells and selective toxicity of chemotherapeutic agents. Gastroenterology 2012;143:234-245. e237.
-
(2012)
Gastroenterology
, vol.143
, pp. 234-245
-
-
Adikrisna, R.1
Tanaka, S.2
Muramatsu, S.3
-
33
-
-
79960607503
-
A pilot study to investigate the role of the 26S proteasome in radiotherapy resistance and loco-regional recurrence following breast conserving therapy for early breast cancer
-
Elfadl D, Hodgkinson VC, Long ED et al. A pilot study to investigate the role of the 26S proteasome in radiotherapy resistance and loco-regional recurrence following breast conserving therapy for early breast cancer. Breast 2011;20:334-337.
-
(2011)
Breast
, vol.20
, pp. 334-337
-
-
Elfadl, D.1
Hodgkinson, V.C.2
Long, E.D.3
-
34
-
-
26844545414
-
The proteasome inhibitor MG-132 sensitizes PC-3 prostate cancer cells to ionizing radiation by a DNA-PK-independent mechanism
-
Pajonk F, van Ophoven A, Weissenberger C et al. The proteasome inhibitor MG-132 sensitizes PC-3 prostate cancer cells to ionizing radiation by a DNA-PK-independent mechanism. BMC Cancer 2005;5:76.
-
(2005)
BMC Cancer
, vol.5
, pp. 76
-
-
Pajonk, F.1
Van Ophoven, A.2
Weissenberger, C.3
-
36
-
-
0037105651
-
The human immunodeficiency virus (HIV)21 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells
-
Pajonk F, Himmelsbach J, Riess K et al. The human immunodeficiency virus (HIV)21 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells. Cancer Res 2002;62:5230-5235.
-
(2002)
Cancer Res
, vol.62
, pp. 5230-5235
-
-
Pajonk, F.1
Himmelsbach, J.2
Riess, K.3
-
37
-
-
0035337151
-
Ionizing radiation affects 26s proteasome function and associated molecular responses, even at low doses
-
Pajonk F, McBride WH. Ionizing radiation affects 26s proteasome function and associated molecular responses, even at low doses. Radiother Oncol 2001;59:203-212.
-
(2001)
Radiother Oncol
, vol.59
, pp. 203-212
-
-
Pajonk, F.1
McBride, W.H.2
-
38
-
-
19644388720
-
Hyperthermia-induced proteasome inhibition and loss of androgen receptor expression in human prostate cancer cells
-
Pajonk F, van Ophoven A, McBride WH. Hyperthermia-induced proteasome inhibition and loss of androgen receptor expression in human prostate cancer cells. Cancer Res 2005;65:4836-4843.
-
(2005)
Cancer Res
, vol.65
, pp. 4836-4843
-
-
Pajonk, F.1
Van Ophoven, A.2
McBride, W.H.3
-
39
-
-
26844582835
-
Anthracyclines, proteasome activity and mult-drug-resistance
-
Fekete MR,McBride WH, Pajonk F. Anthracyclines, proteasome activity and mult-drug-resistance. BMC Cancer 2005;5:114.
-
(2005)
BMC Cancer
, vol.5
, pp. 114
-
-
Fekete, M.R.1
McBride, W.H.2
Pajonk, F.3
-
40
-
-
84856283124
-
A phase II study of the combination of endocrine treatment and bortezomib in patients with endocrine-resistant metastatic breast cancer
-
Trinh XB, Sas L, Van Laere SJ et al. A phase II study of the combination of endocrine treatment and bortezomib in patients with endocrine-resistant metastatic breast cancer. Oncol Rep 2012;27:657-663.
-
(2012)
Oncol Rep
, vol.27
, pp. 657-663
-
-
Trinh, X.B.1
Sas, L.2
Van Laere, S.J.3
-
41
-
-
79952277119
-
Phase II study of bortezomib and pegylated liposomal doxorubicin in the treatment of metastatic breast cancer
-
Irvin WJ, Jr., Orlowski RZ, Chiu WK et al. Phase II study of bortezomib and pegylated liposomal doxorubicin in the treatment of metastatic breast cancer. Clin Breast Cancer 2010;10:465-470.
-
(2010)
Clin Breast Cancer
, vol.10
, pp. 465-470
-
-
Irvin Jr., W.J.1
Orlowski, R.Z.2
Chiu, W.K.3
-
42
-
-
76749130692
-
Randomized phase II trial of docetaxel plus cetuximab or docetaxel plus bortezomib in patients with advanced non-small-cell lung cancer and a performance status of 2: CALGB 30402
-
Lilenbaum R, Wang X, Gu L et al. Randomized phase II trial of docetaxel plus cetuximab or docetaxel plus bortezomib in patients with advanced non-small-cell lung cancer and a performance status of 2: CALGB 30402. J Clin Oncol 2009;27:4487-4491.
-
(2009)
J Clin Oncol
, vol.27
, pp. 4487-4491
-
-
Lilenbaum, R.1
Wang, X.2
Gu, L.3
-
43
-
-
84859538161
-
Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: A north central cancer treatment group study
-
Friday BB, Anderson SK, Buckner J et al. Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: A north central cancer treatment group study. Neuro Oncol 2012;14:215-221.
-
(2012)
Neuro Oncol
, vol.14
, pp. 215-221
-
-
Friday, B.B.1
Anderson, S.K.2
Buckner, J.3
-
44
-
-
79960403334
-
Combination therapy of recurrent prostate cancer with the proteasome inhibitor bortezomib plus hormone blockade
-
Kraft AS, Garrett-Mayer E, Wahlquist AE et al. Combination therapy of recurrent prostate cancer with the proteasome inhibitor bortezomib plus hormone blockade. Cancer Biol Ther 2011;12:119-124.
-
(2011)
Cancer Biol Ther
, vol.12
, pp. 119-124
-
-
Kraft, A.S.1
Garrett-Mayer, E.2
Wahlquist, A.E.3
-
45
-
-
77950841318
-
A phase i study of bortezomib in combination with standard 5-fluorouracil and externalbeam radiation therapy for the treatment of locally advanced or metastatic rectal cancer
-
O'Neil BH, Raftery L, Calvo BF et al. A phase I study of bortezomib in combination with standard 5-fluorouracil and externalbeam radiation therapy for the treatment of locally advanced or metastatic rectal cancer. Clin Colorectal Cancer 2010;9:119-125.
-
(2010)
Clin Colorectal Cancer
, vol.9
, pp. 119-125
-
-
O'Neil, B.H.1
Raftery, L.2
Calvo, B.F.3
-
46
-
-
57849167014
-
Proteasome subunits are regulated and expressed in comparable concentrations as a functional cluster
-
Sato Y, Sakamoto K, Sei M et al. Proteasome subunits are regulated and expressed in comparable concentrations as a functional cluster. Biochem Biophys Res Commun 2009;378:795-798.
-
(2009)
Biochem Biophys Res Commun
, vol.378
, pp. 795-798
-
-
Sato, Y.1
Sakamoto, K.2
Sei, M.3
-
47
-
-
0031579450
-
Structural properties and RNA-binding activities of two RNA recognition motifs of a mouse neural RNA-binding protein, mouse-Musashi-1
-
Kurihara Y, Nagata T, Imai T et al. Structural properties and RNA-binding activities of two RNA recognition motifs of a mouse neural RNA-binding protein, mouse-Musashi-1. Gene 1997;186:21-27.
-
(1997)
Gene
, vol.186
, pp. 21-27
-
-
Kurihara, Y.1
Nagata, T.2
Imai, T.3
-
48
-
-
30044442091
-
The RNA-binding protein Musashi-1 regulates neural development through the translational repression of p21WAF-1
-
Battelli C, Nikopoulos GN, Mitchell JG et al. The RNA-binding protein Musashi-1 regulates neural development through the translational repression of p21WAF-1. Mol Cell Neurosci 2006;31:85-96.
-
(2006)
Mol Cell Neurosci
, vol.31
, pp. 85-96
-
-
Battelli, C.1
Nikopoulos, G.N.2
Mitchell, J.G.3
-
49
-
-
66449137078
-
Genomic analyses of musashi1 downstream targets show a strong association with cancer-related processes
-
de Sousa Abreu R, Sanchez-Diaz PC, Vogel C et al. Genomic analyses of musashi1 downstream targets show a strong association with cancer-related processes. J Biol Chem 2009;284:12125-12135.
-
(2009)
J Biol Chem
, vol.284
, pp. 12125-12135
-
-
De Sousa Abreu, R.1
Sanchez-Diaz, P.C.2
Vogel, C.3
-
50
-
-
84856877564
-
NF-Y is necessary for hematopoietic stem cell proliferation and survival
-
Bungartz G, Land H, Scadden DT et al. NF-Y is necessary for hematopoietic stem cell proliferation and survival. Blood 2012;119:1380-1389.
-
(2012)
Blood
, vol.119
, pp. 1380-1389
-
-
Bungartz, G.1
Land, H.2
Scadden, D.T.3
-
51
-
-
33646744719
-
Elimination of damaged proteins during differentiation of embryonic stem cells
-
Hernebring M, Brolen G, Aguilaniu H et al. Elimination of damaged proteins during differentiation of embryonic stem cells. Proc Natl Acad Sci USA 2006;103:7700-7705.
-
(2006)
Proc Natl Acad Sci USA
, vol.103
, pp. 7700-7705
-
-
Hernebring, M.1
Brolen, G.2
Aguilaniu, H.3
-
52
-
-
84867912887
-
The short isoform of NF-YA belongs to the embryonic stem cell transcription factor circuitry
-
Dolfini D, Minuzzo M, Pavesi G, Mantovani R. The short isoform of NF-YA belongs to the embryonic stem cell transcription factor circuitry. Stem Cells 2012;30: 2450-2459.
-
(2012)
Stem Cells
, vol.30
, pp. 2450-2459
-
-
Dolfini, D.1
Minuzzo, M.2
Pavesi, G.3
Mantovani, R.4
|